Effect of Insulin Therapy using Hyper-insulinemic Normoglycemic Clamp on Inflammatory Response in Brain Dead Organ Donors

Abstract

Background: Brain death is a major stress that is associated with a massive inflammatory response and systemic hyperglycemia. Severe inflammation leads to increased graft immunogenicity and risk of graft dysfunction; while acute hyperglycemia aggravates the inflammatory response and increases the risk of morbidity and mortality. Insulin therapy not only controls hyperglycemia but also suppresses inflammation. The present study is to investigate the anti-inflammatory properties and the normoglycemia maintenance of high dose insulin on brain dead organ donors.

Design: 15 brain dead organ donors were divided into 2 groups, insulin treated (n=6) and controls (n=9). Insulin was provided for a minimum of 6 h using the hyperinsulinemic normoglycemic clamp technique. The changes of serum cytokines, including IL-6, IL-10, IL-1β, IL-8, TNFα, TGFα and MCP-1, were measured by suspension bead array immunoassay and glucose by a glucose monitor.

Results: Compared to controls, insulin treated donors had a significant lower blood glucose 4.8 (4–6.9) vs. 9 (5.6–11.7) mmol/L, p<0.01); the net decreases of pro-inflammatory cytokines, such as IL-6 and MCP-1, and the net increase of anti-inflammatory cytokine, such as IL-10, reached significant level in insulin treated donors compared with those in controls.

Conclusion: High dose insulin therapy decreases the concentrations of inflammatory cytokines in brain dead donors and preserves normoglycemia. High dose of insulin may have anti-inflammatory effects in brain dead organ donors and therefore, improve the quality of donor organs and potentially improve outcomes.

Key words

hormones - adipocytokines - transplantation - brain dead donors - inflammation

^* Contributed equally as first authors

• References

• 1 Rosendale JD, Kauffman HM, McBride MA et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75: 482-487
• 2 Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand. 2009; 53: 1239-1250
• 3 Barklin A. Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 2009; 53: 425-435
• 4 Murugan R, Venkataraman R, Wahed AS et al. Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation. Crit Care Med 2008; 36: 1810-1816
• 5 van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 1359-1366
• 6 Ambiru S, Kato A, Kimura F et al. Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. J Hosp Infect 2008; 68: 230-233
• 7 Albacker T, Carvalho G, Schricker T et al. High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. Ann Thorac Surg 2008; 86: 20-27
• 8 Monge M, Ledeme N, Mazouz H et al. Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. Nephrol Dial Transplant 2007; 22: 1979-1985
• 9 Caraceni P, Nardo B, Domenicali M et al. Ischemia-reperfusion injury in rat fatty liver: role of nutritional status. Hepatology 1999; 29: 1139-1146
• 10 Le Couteur DG, Rivory LP, Pond SM. The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. Transplantation 1994; 58: 531-536
• 11 Nettelbladt CG, Alibergovic A, Ljungqvist O. Pre-stress carbohydrate solution prevents fatal outcome after hemorrhage in 24-h food-deprived rats. Nutrition 1996; 12: 696-699
• 12 Astarcioglu I, Adam R, Gigou M et al. High levels of glycogen in the donor liver improve survival after liver transplantation in rats. Transplant Proc 1991; 23: 2465-2466
• 13 Hassanain M, Schricker T, Metrakos P et al. Hepatic protection by perioperative metabolic support?. Nutrition 2008; 24: 1217-1219
• 14 Fisette A, Hassanain M, Metrakos P et al. High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. J Clin Endocrinol Metab 2012; 97: 217-226
• 15 Kim YI, Hwang YJ, Song KE et al. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. J Am Coll Surg 2002; 195: 41-50
• 16 Marfella R, Di Filippo C, Portoghese M et al. Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. J Am Coll Cardiol 2009; 53: 1425-1436
• 17 Turina M, Fry DE, Polk Jr HC. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005; 33: 1624-1633
• 18 Ott L, McClain CJ, Gillespie M et al. Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma 1994; 11: 447-472
• 19 Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-867
• 20 Fisher AJ, Donnelly SC, Hirani N et al. Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury. Lancet 1999; 353: 1412-1413
• 21 Hierholzer C, Billiar TR. Molecular mechanisms in the early phase of hemorrhagic shock. Langenbecks Arch Surg 2001; 386: 302-308
• 22 Yoshimoto Y, Tanaka Y, Hoya K. Acute systemic inflammatory response syndrome in subarachnoid hemorrhage. Stroke 2001; 32: 1989-1993
• 23 Karimova A, Pinsky DJ. The endothelial response to oxygen deprivation: biology and clinical implications. Intensive Care Med 2001; 27: 19-31
• 24 Deng MC, Erren M, Kammerling L et al. The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. Transplantation 1995; 60: 1118-1124
• 25 Birks EJ, Burton PB, Owen V et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 2000; 102 (Suppl. 03) III352-III358
• 26 Kusaka M, Pratschke J, Wilhelm MJ et al. Early and late inflammatory changes occurring in rat renal isografts from brain dead donors. Transplant Proc 2001; 33: 867-868
• 27 Koo DD, Welsh KI, McLaren AJ et al. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. Kidney Int 1999; 56: 1551-1559
• 28 Pratschke J, Neuhaus P, Tullius SG. What can be learned from brain-death models?. Transpl Int 2005; 18: 15-21
• 29 Birks EJ, Owen VJ, Burton PB et al. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation 2000; 102: 326-331
• 30 Kotsch K, Ulrich F, Reutzel-Selke A et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248: 1042-1050
• 31 Lloyd CM, Minto AW, Dorf ME et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. The Journal of experimental medicine 1997; 185: 1371-1380
• 32 Valderhaug TG, Hjelmesaeth J, Jenssen T et al. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Transplantation 2012; 94: 714-720
• 33 Barklin A, Larsson A, Vestergaard C et al. Insulin alters cytokine content in two pivotal organs after brain death: a porcine model. Acta Anaesthesiol Scand 2008; 52: 628-634